The Role of Autoimmunity and Obesity in Polycystic Ovary Syndrome
NCT05929950 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2023-07-03
Summary
The goal of the study is to detect autoantibodies in the serum of the women with PCOS and evaluate the obesity markers to investigate the the role of autoimmunity and obesity in PCOS
Conditions
- Polycystic Ovary Syndrome
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 12 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-08-01
- Primary Completion
- 2024-03-01
- Completion
- 2024-06-01
Countries
- Egypt
Study Locations
More Related Trials
-
Activity of Chronic Inflammation in PCOS
NCT06300593 ·Status: COMPLETED
-
Health-related Quality of Life of Women with Polycystic Ovary Syndrome At Sohag University Hospital
NCT06832735 ·Status: NOT_YET_RECRUITING
-
The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Cohort Study
NCT05734287 ·Status: RECRUITING
-
Women With Polycystic Ovary Syndrome Are at High Risk for Cardiac Insults
NCT05344547 ·Status: COMPLETED
-
Adipose Tissue Gene Expression Profiles in Women With Polycystic Ovary Syndrome (PCOS) Versus Controls
NCT01195142 ·Status: COMPLETED
-
Comparison of Lifestyle Markers Between Women With and Without Polycystic Ovary Syndrome
NCT01859663 ·Status: COMPLETED
-
Evaluation of Serum Scube-1 Scube-2 and Scube-3 Levels in Patients With Polikistik Over Syndrome ,
NCT03765905 ·Status: COMPLETED
-
To Study Polycystic Ovary Syndrome in Taiwanese Women
NCT01256944 ·Status: COMPLETED
-
Surgical and Non Surgical Treatment Option in Poly Cystic Ovary Cases
NCT05699356 ·Status: UNKNOWN
-
Epicardial Adipose Tissue Thickness in Polycystic Ovary Syndrome (PCOS)
NCT01258946 ·Status: COMPLETED
-
Adipose Expression of Leptin, Adiponectin and IL-6 and Plasma Levels of Adipocytokines in Women With and Without Polycystic Ovary Syndrome (PCOS)
NCT01088061 ·Status: COMPLETED
-
IR, Inflammatory and Cardiovascular Markers in PCOS Among Obese and Non-obese Women
NCT01989039 ·Status: UNKNOWN
-
Ovarian Reserve in Patients With Psoriasis
NCT03492632 ·Status: COMPLETED
-
Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
NCT05843955 ·Status: COMPLETED
-
Cardiovascular Risk Markers in Polycystic Ovary Syndrome (PCOS)
NCT01195168 ·Status: COMPLETED
-
Post-Prandial Liver Glucose Metabolism in PCOS
NCT03041129 ·Status: COMPLETED
-
The Effects of the Mediterranean Diet and Synbiotics in Polycystic Ovary Syndrome
NCT07342946 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intestinal Microbiota Survey of Polycystic Ovary Syndrome
NCT02937090 ·Status: COMPLETED
-
Pro- and Anti-inflammatory Cytokines in PCOS
NCT06793085 ·Status: RECRUITING
-
Serum Fetuin Level in Polycystic Ovary Syndrome
NCT03819998 ·Status: UNKNOWN
-
PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease
NCT07146815 ·Status: COMPLETED ·Phase: NA
-
Expression of CVD and HA Between Obesity and Non-obesity Polycystic Ovary Syndrome (PCOS) Women in Taiwan
NCT01113918 ·Status: COMPLETED
-
Analysis of Clinical Characteristics and Study of Diagnostic Markers in Patients with Polycystic Ovary Syndrome
NCT05063383 ·Status: RECRUITING
-
Prevalence of HbA1C in Women With PCOS
NCT01838122 ·Status: UNKNOWN
-
Serum Metabolomics Study of Polycystic Ovary Syndrome
NCT03618342 ·Status: UNKNOWN